Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

BRIEF-Neovasc says German Court partially found in favor of Edwards Lifesciences in its case against co

Published 2017-06-16, 11:46 a/m
© Reuters.  BRIEF-Neovasc says German Court partially found in favor of Edwards Lifesciences in its case against co
EW
-
NVCN
-

June 16 (Reuters) - Neovasc Inc NVCN.TO :

* Neovasc announces German Court ruling

* District court in Munich has partially found in favour of Edwards Lifesciences Corporation (NYSE:EW) in its case against Neovasc

* German Court found CardiAQ had contributed in part to invention of Tiara, awarded to CardiAQ co-entitlement rights to disputed Tiara European patent application

* Neovasc intends to appeal Court's decision

* There are no monetary awards associated with the Court ruling

* Currently appealing 2016 decision from U.S Court which granted co-inventorship rights to Edwards on one of co's granted U.S. patent applications

* Expects oral argument on appeal regarding the 2016 decision by U.S. Court in August 2017 and ruling is expected to follow, prior to end of 2017 Source text for Eikon: ID:nPn7QlKtLa Further company coverage: NVCN.TO

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.